Skip to main content
Fig. 4 | BMC Veterinary Research

Fig. 4

From: Curcumin-infused nanostructured lipid carriers: a promising strategy for enhancing skin regeneration and combating microbial infection

Fig. 4

Assessment of the antibacterial and antifungal activity of Curcumin and CURC-NLCs. (A) Antibacterial activity of Curcumin and CURC-NLCs against different bacterial species as Bacillus subtilis ATCC 6633, Salmonella spp, Staphylococcus aureus ATCC 25,923, Staphylococcus epidermis, and Escherichia coli ATCC 25,922 using inhibition zone diameter (IZD) and minimal inhibitory concentration (MIC). (B) Antifungal activity of CURC-EXTR and CURC-NLCs against Candida albicans EMCC 105. (C & D) Quantitative analysis of IZD and MIC, data was represented as mean ± SD (nsp > 0.05, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001)

Back to article page